biblio
“Challenges associated with metal chelation therapy in alzheimer's disease”, Journal of Alzheimers Disease, vol. 17, no. 3, pp. 457-468, 2009.
, “Facile enantioselective synthesis of (S)-N-(5-chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol via proline-catalyzed asymmetric alpha-aminooxylation and alpha-amination of aldehyde”, Tetrahedron Letters, vol. 51, no. 50, pp. 6565-6567, 2010.
, “Basic structural motif and major biophysical properties of Amyloid-beta are encoded in the fragment 18-35”, Chemical Physics, vol. 422, pp. 80-87, 2013.
, “Multi-faceted role of melatonin in neuroprotection and amelioration of tau aggregates in alzheimer's disease”, Journal of Alzheimers Disease, vol. 62, no. 4, pp. 1481-1493, 2018.
, “Actin-mediated microglial chemotaxis via G-protein coupled purinergic receptor in alzheimer's disease”, Neuroscience, vol. 448, pp. 325-336, 2020.
, “Autophagic pathways to clear the tau aggregates in alzheimer's disease”, Cellular and Molecular Neurobiology, 2020.
, “Cobalt-based metal complexes prevent repeat tau aggregation and nontoxic to neuronal cells”, International Journal of Biological Macromolecules, vol. 152, pp. 171-179, 2020.
, “Effect of melatonin on tau aggregation and tau-mediated cell surface morphology”, International Journal of Biological Macromolecules, vol. 152, pp. 30-39, 2020.
, “G-protein coupled receptors and tau-different roles in alzheimer's disease”, Neuroscience, vol. 438, pp. 198-214, 2020.
, “Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation”, Cell and Bioscience, vol. 10, no. 1, p. 109, 2020.
, “Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments”, Biochimica Et Biophysica Acta-General Subjects, vol. 1864, p. 129467, 2020.
, “P301 L, an FTDP-17 mutant, exhibits enhanced glycation in vitro”, Journal of Alzheimers Disease, vol. 75, no. 1, pp. 61-71, 2020.
, “Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia”, Journal of Neuroinflammation, vol. 17, no. 1, p. 10, 2020.
, “Role of microglia in regulating cholesterol and tau pathology in alzheimer's disease”, Cellular and Molecular Neurobiology, 2020.
, “Transition metal nickel prevents Tau aggregation in Alzheimer's disease”, International Journal of Biological Macromolecules, vol. 156, pp. 1359-1365, 2020.
, “Alpha-Linolenic acid inhibits Tau aggregation and modulates Tau conformation”, International Journal of Biological Macromolecules, vol. 166, pp. 687-693, 2021.
, “Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation”, Cell Communication and Signaling, vol. 19, no. 1, p. 16, 2021.
, “Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer's disease”, Cell Communication and Signaling, vol. 19, no. 1, p. 28, 2021.
, “Protriptyline improves spatial memory and reduces oxidative damage by regulating NF kappa B-BDNF/CREB signaling axis in streptozotocin-induced rat model of Alzheimer's disease”, Brain Research, vol. 1754, p. 147261, 2021.
, “G-protein coupled purinergic P2Y12 receptor interacts and internalizes Tau(RD)-mediated by membrane-associated actin cytoskeleton remodeling in microglia”, European Journal of Cell Biology, vol. 101, no. 2, p. 151201, 2022.
, “TGF-beta 1 signalling in Alzheimer's pathology and cytoskeletal reorganization: a specialized Tau perspective”, Journal of Neuroinflammation, vol. 20, no. 1, p. 72, 2023.
,